Tailin Biotech: Announcement on the conditions expected to trigger the adjustment of Tailin's debt-to-equity conversion price
Tailin Biotech: Announcement on the 2022 interest payment of Tailin's debt
Tailin Biotech: Announcement on a 10% change in convertible bond holding ratio
Tailin Biotech: 2021 Zhejiang Tailin Biotechnology Co., Ltd. GEM issued convertible corporate bonds to unspecified targets 2022 tracking rating report
Tailin Biotech: 2021 Equity Distribution Implementation Notice
Tailin Biotech: Announcement on 2021 Profit Distribution Plan
Tailin Biotech: Online Roadshow Announcement on Issuance of Convertible Corporate Bonds to Unspecified Targets
Tailin Biotech: Issuance of Convertible Corporate Bonds to Unspecified Targets and Sponsors
Tailin Biotech: Issuer and Sponsor's Response to the Listing Committee's Review and Implementation Letter
Tailin Biology: Implementation letter on the review opinions of the listing committee of Zhejiang Tailin Biotechnology Co., Ltd.
Tailin Biotech: Responses from issuers and sponsors to the Audit Centre's opinion implementation letter
Tailin Biotech: Notice on receipt of the “Audit and Implementation Letter on Zhejiang Tailin Biotechnology Co., Ltd.'s Application for Issuance of Convertible Corporate Bonds to Unspecified Targets” from the Shenzhen Stock Exchange
Tailin Biology: Implementation letter from the Audit Center on Zhejiang Tailin Biotechnology Co., Ltd.'s application to issue convertible corporate bonds to unspecified targets
Tailin Biotech: 7-3 Supplemental Legal Opinion (1) (Second revised draft)
Tailin Biotech: 7-1 Issuer and Sponsor Agency's Response Report to the Audit Enquiry Letter (Second Revised Draft)
Tailin Biotech: 7-2 Tianjian Certified Public Accountants Special Instructions on the Audit Inquiry Letter (Second Revised Draft)
Tailin Biotech: 3-1 Securities Issuance Sponsorship Letter (Application Draft)
Tailin Biotech: 3-3 Listing Sponsorship Letter (Application Draft)
Tailin Biotech: 1-1 Application Instructions (Application Draft)
Tailin Biotech: 3-1 Securities Issuance Sponsorship Letter (Application Draft)
No Data